News

Deal Announcements

Bone Biologics Banks $2 Million Venture Funding

Friday, May 8, 2015 5:33:00 AM PDT | VentureDeal
   Edison, New Jersey  --  Biotechnology company Bone Biologics has received $2 million in development stage funding.

Bone Bio is commercializing a technology it licensed from UCLA to assist in creating bone formation without undesirable side effects such as ectopic bone growth or cyst formation.

Hankey Capital made the investment.

The company said it would use the funding to continue development in preparation for human clinical trials for its regenerative bone treatment.

Bone Bio was founded in 2004 by Dr. Eric Tang, chairman of The UCLA Department of Surgery.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1